Published in PLoS One on December 10, 2013
Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89
Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins. PLoS Pathog (2015) 0.85
Sequence of events in measles virus replication: role of phosphoprotein-nucleocapsid interactions. J Virol (2014) 0.82
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
Budding of rabies virus particles in the absence of the spike glycoprotein. Cell (1996) 4.46
Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc Natl Acad Sci U S A (1989) 4.26
Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol (2000) 3.77
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40
Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology (1990) 2.24
The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J (1997) 2.10
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Cell (1985) 2.01
Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. J Virol (1992) 1.89
Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J Biol Chem (2001) 1.87
Efficient export of the vesicular stomatitis virus G protein from the endoplasmic reticulum requires a signal in the cytoplasmic tail that includes both tyrosine-based and di-acidic motifs. Mol Biol Cell (2000) 1.68
Molecular mechanism of paramyxovirus budding. Virus Res (2004) 1.65
Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J Virol (1999) 1.64
Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo. J Virol (1994) 1.61
Role of matrix and fusion proteins in budding of Sendai virus. J Virol (2001) 1.58
Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J Virol (2002) 1.51
Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J Virol (1998) 1.43
A sensitive plaque assay for Sendai virus in an established line of monkey kidney cells. Jpn J Microbiol (1974) 1.40
Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology (2000) 1.39
More than one door - Budding of enveloped viruses through cellular membranes. FEBS Lett (2007) 1.35
Budding efficiency of Sendai virus nucleocapsids: influence of size and ends of the RNA. Virus Res (1989) 1.24
Sendai virus assembly: M protein binds to viral glycoproteins in transit through the secretory pathway. J Virol (1993) 1.22
The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol (2006) 1.18
Structure-function analysis of the Sendai virus F and HN cytoplasmic domain: different role for the two proteins in the production of virus particle. Virology (2000) 1.13
Measles virus nucleocapsid transport to the plasma membrane requires stable expression and surface accumulation of the viral matrix protein. Cell Microbiol (2007) 1.05
Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins. J Virol (1986) 1.04
Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology (2007) 1.02
A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding. Virology (1996) 1.00
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
The why's of Y-based motifs in alphaherpesvirus envelope proteins. Virus Res (2006) 0.85
Establishment of Sendai virus persistent infection: biochemical analysis of the early phase of a standard plus defective interfering virus infection of BHK cells. Virology (1981) 0.85
Sendai virus particle production: basic requirements and role of the SYWST motif present in HN cytoplasmic tail. Virology (2010) 0.84
Critical role of the fusion protein cytoplasmic tail sequence in parainfluenza virus assembly. PLoS One (2013) 0.82
Glycoprotein targeting signals influence the distribution of measles virus envelope proteins and virus spread in lymphocytes. J Gen Virol (2008) 0.81
Direct adverse effects of Sendai virus DI particles on virus budding and on M protein fate and stability. Virology (1988) 0.80
Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell (2011) 4.11
Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev (2003) 2.68
Paramyxovirus mRNA editing, the "rule of six" and error catastrophe: a hypothesis. J Gen Virol (2005) 2.19
Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One (2007) 2.18
Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol (2002) 1.97
A physical and functional link between cholesterol and tetraspanins. Eur J Immunol (2003) 1.54
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. Eur J Pediatr (2002) 1.40
Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun (2003) 1.34
Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J Immunol (2008) 1.20
Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J Virol Methods (2005) 1.18
Paramyxovirus ultrastructure and genome packaging: cryo-electron tomography of sendai virus. J Virol (2009) 1.11
Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J Biol Chem (2003) 1.10
Nipah virus uses leukocytes for efficient dissemination within a host. J Virol (2011) 1.05
Rapid titration of measles and other viruses: optimization with determination of replication cycle length. PLoS One (2011) 1.04
Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology (2007) 1.02
Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol (2005) 0.99
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy. Viral Immunol (2006) 0.94
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
Cell surface activation of the alternative complement pathway by the fusion protein of measles virus. J Gen Virol (2004) 0.92
Given the opportunity, the Sendai virus RNA-dependent RNA polymerase could as well enter its template internally. J Virol (2002) 0.90
Refined study of the interaction between HIV-1 p6 late domain and ALIX. Retrovirology (2008) 0.89
Plasticity in structural and functional interactions between the phosphoprotein and nucleoprotein of measles virus. J Biol Chem (2012) 0.88
Nature of a paramyxovirus replication promoter influences a nearby transcription signal. J Gen Virol (2005) 0.88
From assembly to virus particle budding: pertinence of the detergent resistant membranes. Virology (2005) 0.86
Sendai virus particle production: basic requirements and role of the SYWST motif present in HN cytoplasmic tail. Virology (2010) 0.84
Antagonism to human BST-2/tetherin by Sendai virus glycoproteins. J Gen Virol (2013) 0.84
High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system. BMC Biotechnol (2007) 0.81
Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus. Virus Res (2010) 0.80
Sendai virus induced cytoplasmic actin remodeling correlates with efficient virus particle production. Virology (2010) 0.79
Selection of single-chain antibodies that specifically interact with vesicular stomatitis virus (VSV) nucleocapsid and inhibit viral RNA synthesis. J Virol Methods (2005) 0.79
Structure of the measles virus H glycoprotein sheds light on an efficient vaccine. Proc Natl Acad Sci U S A (2007) 0.79
The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment. Virol J (2009) 0.78
High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation. Mol Immunol (2008) 0.78
A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus. J Gen Virol (2002) 0.77
Dissecting partner recognition by an intrinsically disordered protein using descriptive random mutagenesis. J Mol Biol (2013) 0.77
Further characterization of a paramyxovirus transcription initiation signal: search for required nucleotides upstream and importance of the N phase context. J Gen Virol (2007) 0.77
Replication and packaging properties of short Paramyxovirus defective RNAs. Virus Res (2004) 0.77
Transcribing paramyxovirus RNA polymerase engages the template at its 3' extremity. J Gen Virol (2006) 0.77
Heparan sulfate-dependent enhancement of henipavirus infection. MBio (2015) 0.76
Minimal features of efficient incorporation of the hemagglutinin-neuraminidase protein into sendai virus particles. J Virol (2013) 0.75
High throughput screening assay for negative single stranded RNA virus polymerase inhibitors. J Virol Methods (2005) 0.75
Transmission enhancement through square coaxial aperture arrays in metallic film: when leaky modes filter infrared light for multispectral imaging. Opt Lett (2014) 0.75
Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract. Emerg Microbes Infect (2022) 0.75
Occlusive idiopathic juxtafoveolar retinal telangiectasis type 4. Can J Ophthalmol (2013) 0.75
The cellular protein TIP47 restricts Respirovirus multiplication leading to decreased virus particle production. Virus Res (2013) 0.75
[RIG-I: a viral RNA detector molecular switch]. Med Sci (Paris) (2012) 0.75